Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option

Por Bohn, Jan-Paul, Gastl, Guenther, Steurer, Michael
Publicado no Memo (2016)

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

Por Martowicz, Agnieszka, Spizzo, Gilbert, Gastl, Guenther, Untergasser, Gerold
Publicado em 2012

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Por Boesch, Maximilian, Hoflehner, Elisabeth, Wolf, Dominik, Gastl, Guenther, Sopper, Sieghart
Publicado no J Vis Exp (2017)

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth

Por Martowicz, Agnieszka, Rainer, Johannes, Lelong, Julien, Spizzo, Gilbert, Gastl, Guenther, Untergasser, Gerold
Publicado em 2013

Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies

Por Zimmer, Kai, Kocher, Florian, Spizzo, Gilbert, Salem, Mohamed, Gastl, Guenther, Seeber, Andreas
Publicado no Comput Struct Biotechnol J (2019)

Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics

Por Boesch, Maximilian, Zeimet, Alain G., Rumpold, Holger, Gastl, Guenther, Sopper, Sieghart, Wolf, Dominik
Publicado no Stem Cells Transl Med (2015)

Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment

Por Spizzo, Gilbert, Siebert, Uwe, Gastl, Guenther, Voss, Andreas, Schuster, Klaus, Leonard, Robert, Seeber, Andreas
Publicado no Cost Eff Resour Alloc (2019)

Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche

Por Boesch, Maximilian, Sopper, Sieghart, Zeimet, Alain G., Reimer, Daniel, Gastl, Guenther, Ludewig, Burkhard, Wolf, Dominik
Publicado no Biochim Biophys Acta (2016)

Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas

Por Fong, Dominic, Seeber, Andreas, Terracciano, Luigi, Kasal, Armin, Mazzoleni, Guido, Lehne, Florian, Gastl, Guenther, Spizzo, Gilbert
Publicado em 2014

Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro

Por Seeber, Andreas, Martowicz, Agnieszka, Spizzo, Gilbert, Buratti, Thomas, Obrist, Peter, Fong, Dominic, Gastl, Guenther, Untergasser, Gerold
Publicado no BMC Cancer (2015)

The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation

Por Wolf, Anna Maria, Wolf, Dominik, Rumpold, Holger, Ludwiczek, Susanne, Enrich, Barbara, Gastl, Guenther, Weiss, Guenter, Tilg, Herbert
Publicado em 2005

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

Por Spizzo, Gilbert, Fong, Dominic, Wurm, Martin, Ensinger, Christian, Obrist, Peter, Hofer, Carina, Mazzoleni, Guido, Gastl, Guenther, Went, Philip
Publicado em 2011

High prevalence of side population in human cancer cell lines

Por Boesch, Maximilian, Zeimet, Alain G., Fiegl, Heidi, Wolf, Barbara, Huber, Julia, Klocker, Helmut, Gastl, Guenther, Sopper, Sieghart, Wolf, Dominik
Publicado no Oncoscience (2016)

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics

Por Boesch, Maximilian, Zeimet, Alain G., Reimer, Daniel, Schmidt, Stefan, Gastl, Guenther, Parson, Walther, Spoeck, Franziska, Hatina, Jiri, Wolf, Dominik, Sopper, Sieghart
Publicado em 2014

Effects of EpCAM overexpression on human breast cancer cell lines

Por Gostner, Johanna M, Fong, Dominic, Wrulich, Oliver A, Lehne, Florian, Zitt, Marion, Hermann, Martin, Krobitsch, Sylvia, Martowicz, Agnieszka, Gastl, Guenther, Spizzo, Gilbert
Publicado em 2011

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

Por Seeber, Andreas, Braicu, Ioana, Untergasser, Gerold, Nassir, Mani, Fong, Dominic, Botta, Laura, Gastl, Guenther, Fiegl, Heidi, Zeimet, Alain, Sehouli, Jalid, Spizzo, Gilbert
Publicado no Oncotarget (2015)

Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness

Por Boesch, Maximilian, Onder, Lucas, Cheng, Hung-Wei, Novkovic, Mario, Mörbe, Urs, Sopper, Sieghart, Gastl, Guenther, Jochum, Wolfram, Ruhstaller, Thomas, Knauer, Michael, Ludewig, Burkhard
Publicado no Oncoimmunology (2018)

Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

Por Fiedler, Walter, Stoeger, Herbert, Perotti, Antonella, Gastl, Guenther, Weidmann, Jens, Dietrich, Bruno, Baumeister, Hans, Danielczyk, Antje, Goletz, Steffen, Salzberg, Marc, De Dosso, Sara
Publicado no ESMO Open (2018)

Marine compounds inhibit growth of multiple myeloma in vitro and in vivo

Por Steiner, Normann, Ribatti, Domenico, Willenbacher, Wolfgang, Jöhrer, Karin, Kern, Johann, Marinaccio, Christian, Aracil, Miguel, García-Fernández, Luis F., Gastl, Guenther, Untergasser, Gerold, Gunsilius, Eberhard
Publicado no Oncotarget (2015)

Treatment of patients with refractory metastatic cancer according to molecular profiling on tumor tissue in the clinical routine: an interim-analysis of the ONCO-T-PROFILE project

Por Seeber, Andreas, Gastl, Guenther, Ensinger, Christian, Spizzo, Gilbert, Willenbacher, Wolfgang, Kocher, Florian, Leitner, Christoph, Willenbacher, Ella, Amann, Arno, Steiner, Normann, Eisterer, Wolfgang, Voss, Andreas, Russell, Kenneth, Zwierzina, Heinz
Publicado no Genes Cancer (2016)